24 Aug 2022 --- Supported by entrepreneurs, investors and business leaders, the UK-based cannabidiol (CBD) brand TRIP landed US$12 million in its latest investment round. The financial injection will go toward developing the sphere for mental health products “amidst a global mental health crisis.”
